A rational approach towards novel modulators of necroptosis

Detalhes bibliográficos
Autor(a) principal: Ferreira, Maria Beatriz Tomaz
Data de Publicação: 2018
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/53596
Resumo: Necroptosis is a regulated form of necrosis that occurs in response to a cellular damage or infection. It is independent of caspases, occurring under conditions in which the classical pathway of cell death by apoptosis is inhibited. The execution of this type of cell death involves the recruitment of kinases as the RIPK1 and the RIPK3, which give rise to a complex necrosome and lead to the recruitment of the MLKL and consequent phosphorylation, triggering a necroptosis process. RIPK1 and RIPK3 are involved in a wide variety of pathologies for which they currently lack effective treatments, such as stroke, myocardial infarction or acute pancreatitis. Nec-1 was the first known inhibitor for necroptosis, acting through the blockade of RIPK1 activity. However, this presents some problems such as non-specificity for the target. As such, new inhibitors of RIPK1 have been developed, seeking to present better pharmacokinetic and pharmacodynamic properties, focusing on their stability and activity in vivo. Due to the great relevance of these new targets in the treatment of pathologies in which necroptosis is involved and based on a preliminary study of 21 Oxazol-5-(4H)-one derivatives in BV2 and L292 microglial cell lines, a lead compound, OXA 12, was found has an inhibitory activity similar to Nec-1. From OXA 12 and using the Erlenmeyer-Plöch reaction new OXAs were synthesized with the introduction of several groups. Besides these OXAs were further synthesized, altering the hippuric acid by other groups such as the hydrazones. These new compounds were subsequently used for biological evaluation.
id RCAP_5d821dc7e7f3276933393efb59a8be49
oai_identifier_str oai:run.unl.pt:10362/53596
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling A rational approach towards novel modulators of necroptosisOxazol-5-(4H)-onesCell DeathNecroptosisNecrostatinDomínio/Área Científica::Engenharia e Tecnologia::Engenharia QuímicaNecroptosis is a regulated form of necrosis that occurs in response to a cellular damage or infection. It is independent of caspases, occurring under conditions in which the classical pathway of cell death by apoptosis is inhibited. The execution of this type of cell death involves the recruitment of kinases as the RIPK1 and the RIPK3, which give rise to a complex necrosome and lead to the recruitment of the MLKL and consequent phosphorylation, triggering a necroptosis process. RIPK1 and RIPK3 are involved in a wide variety of pathologies for which they currently lack effective treatments, such as stroke, myocardial infarction or acute pancreatitis. Nec-1 was the first known inhibitor for necroptosis, acting through the blockade of RIPK1 activity. However, this presents some problems such as non-specificity for the target. As such, new inhibitors of RIPK1 have been developed, seeking to present better pharmacokinetic and pharmacodynamic properties, focusing on their stability and activity in vivo. Due to the great relevance of these new targets in the treatment of pathologies in which necroptosis is involved and based on a preliminary study of 21 Oxazol-5-(4H)-one derivatives in BV2 and L292 microglial cell lines, a lead compound, OXA 12, was found has an inhibitory activity similar to Nec-1. From OXA 12 and using the Erlenmeyer-Plöch reaction new OXAs were synthesized with the introduction of several groups. Besides these OXAs were further synthesized, altering the hippuric acid by other groups such as the hydrazones. These new compounds were subsequently used for biological evaluation.Afonso, CarlosRavasco, JoãoRUNFerreira, Maria Beatriz Tomaz2020-12-01T01:30:30Z2018-11-1220182018-11-12T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/53596enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:26:27Zoai:run.unl.pt:10362/53596Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:32:39.948942Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv A rational approach towards novel modulators of necroptosis
title A rational approach towards novel modulators of necroptosis
spellingShingle A rational approach towards novel modulators of necroptosis
Ferreira, Maria Beatriz Tomaz
Oxazol-5-(4H)-ones
Cell Death
Necroptosis
Necrostatin
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
title_short A rational approach towards novel modulators of necroptosis
title_full A rational approach towards novel modulators of necroptosis
title_fullStr A rational approach towards novel modulators of necroptosis
title_full_unstemmed A rational approach towards novel modulators of necroptosis
title_sort A rational approach towards novel modulators of necroptosis
author Ferreira, Maria Beatriz Tomaz
author_facet Ferreira, Maria Beatriz Tomaz
author_role author
dc.contributor.none.fl_str_mv Afonso, Carlos
Ravasco, João
RUN
dc.contributor.author.fl_str_mv Ferreira, Maria Beatriz Tomaz
dc.subject.por.fl_str_mv Oxazol-5-(4H)-ones
Cell Death
Necroptosis
Necrostatin
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
topic Oxazol-5-(4H)-ones
Cell Death
Necroptosis
Necrostatin
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
description Necroptosis is a regulated form of necrosis that occurs in response to a cellular damage or infection. It is independent of caspases, occurring under conditions in which the classical pathway of cell death by apoptosis is inhibited. The execution of this type of cell death involves the recruitment of kinases as the RIPK1 and the RIPK3, which give rise to a complex necrosome and lead to the recruitment of the MLKL and consequent phosphorylation, triggering a necroptosis process. RIPK1 and RIPK3 are involved in a wide variety of pathologies for which they currently lack effective treatments, such as stroke, myocardial infarction or acute pancreatitis. Nec-1 was the first known inhibitor for necroptosis, acting through the blockade of RIPK1 activity. However, this presents some problems such as non-specificity for the target. As such, new inhibitors of RIPK1 have been developed, seeking to present better pharmacokinetic and pharmacodynamic properties, focusing on their stability and activity in vivo. Due to the great relevance of these new targets in the treatment of pathologies in which necroptosis is involved and based on a preliminary study of 21 Oxazol-5-(4H)-one derivatives in BV2 and L292 microglial cell lines, a lead compound, OXA 12, was found has an inhibitory activity similar to Nec-1. From OXA 12 and using the Erlenmeyer-Plöch reaction new OXAs were synthesized with the introduction of several groups. Besides these OXAs were further synthesized, altering the hippuric acid by other groups such as the hydrazones. These new compounds were subsequently used for biological evaluation.
publishDate 2018
dc.date.none.fl_str_mv 2018-11-12
2018
2018-11-12T00:00:00Z
2020-12-01T01:30:30Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/53596
url http://hdl.handle.net/10362/53596
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137948434694144